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When ionizing radiation traverses biological material, some energy depositions 
occur and ionize directly deoxyribonucleic acid (DNA) molecules, the critical 
target. A classical paradigm in radiobiology is that the deposition of energy in the 
cell nucleus and the resulting damage to DNA are responsible for the detrimental 
biological effects of radiation. It is presumed that no radiation effect would be 
expected in cells that receive no direct radiation exposure through nucleus. The risks 
of exposure to low dose ionizing radiation are estimated by extrapolating from data 
obtained after exposure to high dose radiation. However, the validity of using this 
dose-response model is controversial because evidence accumulated over the past 
decade has indicated that living organisms, including humans, respond differently to 
low dose radiation than they do to high dose radiation. Moreover, recent 
experimental evidences from many laboratories reveal the fact that radiation effects 
also occur in cells that were not exposed to radiation  and in the progeny of 
irradiated cells at delayed times after radiation exposure where cells do not 
encounter direct DNA damage. Recently, the classical paradigm in radiobiology has 
been shifted from the nucleus, specifically the DNA, as the principal target for the 
biological effects of radiation to cells. The universality of target theory has been 
challenged by phenomena of radiation-induced genomic instability, bystander effect 
and adaptive response. The new radiation biology paradigm would cover both 
targeted and non-targeted effects of ionizing radiation. The mechanisms underlying 
these responses involve biochemical/molecular signals that respond to targeted and 
non-targeted events. These results brought in understanding that the biological 
response to low dose radiation at tissue or organism level is a complex process of 
integrated response of cellular targets as well as extra-cellular factors. Biological 
understanding of the effects of radiation can be used to improve the assessment of 
low dose radiation risk.  In this article, the mechanisms of targeted and non-targeted 
responses, and interrelation between the phenomena on cellular injury after 
exposure to low doses of radiation as they relate to low dose radiation effects              
will be reviewed.  
 
© 2015 Atom Indonesia. All rights reserved 
 
INTRODUCTION 
 
Radiation is potentially harmful to humans 
because the produced ionization can significantly 
alter the structure of molecules within a living               
cell. For many years, the central dogma in 
radiobiology following exposure to all kinds of 
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ionizing radiation has been that the nucleus, 
especially deoxyribonucleic acid (DNA), is the 
principal target for the biological effects of 
radiation. The deleterious effects of ionizing 
radiation include mutation induction, chromosomal 
rearrangement, cellular transformation, 
carcinogenesis and cell death [1]. Extrapolation of 
data from epidemiological investigations requires 
knowledge of the mechanisms of radiation action 
and post-irradiation processes that specifically relate 
to health effects. Biological understanding of the 
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effects of radiation can be used to improve the 
assessment of low dose radiation risk. The health 
effects of concern following low dose radiation 
exposure are cancer and hereditary effects. The lack 
of understanding of the mechanisms of action of 
radiation at low doses is a major contributor to the 
current uncertainty on low dose risk estimates. For 
the purposes of  estimating of risks to human health 
from exposure to low doses of radiation that may be 
received by the general public, workers and patients 
undergoing medical procedure, United Nations 
Scientific Committee on the Effects of Atomic 
Radiation (UNSCEAR) has now defined low doses 
as those of 100 mSv or less [2]. This newly agreed 
definition is consistent with that used by the 
Biological Effects of Ionizing Radiation (BEIR) VII 
Report [3] and International Commission of 
Radiological Protection (ICRP) [4]. 
A classic paradigm in radiation biology is  
that all radiation effects on cells, tissues and 
organisms are due to the direct action of radiation 
on living tissue. Based on this, possible risks from 
exposure to low dose ionizing radiation are 
estimated by extrapolating from data obtained after 
exposure to higher doses of radiation, using a linear 
non-threshold relationship between dose and 
subsequent effect. However, the validity of using 
this dose-response relationship is controversial 
because evidence accumulated over the past decade 
has indicated that living organisms, including 
humans, respond differently to low dose radiation 
than they do to high dose radiation [2,3].  
There is shift in thinking from targeted or 
classical theory that a radiation must hit DNA as the 
only target in order to cause cell damage (effector), 
to the notion that a radiation can hit more than one 
target in exhibition of biological effect, which can 
be the same cell and/or other cells (multiple 
effectors). Meaning that cellular damage is 
expressed in unirradiated neighboring cells near to 
an irradiated cell or cells and in the progeny of 
irradiated cells at delayed times after radiation 
exposure. These results brought in a paradigm shift 
in understanding that the biological response to 
radiation at tissue or organism level is a complex 
process of integrated response of cellular targets as 
well as extra-cellular factors. Phenomena associated 
with fundamental shift in paradigms from 
deterministic hit-effect relationships to complicated 
ongoing cellular responses are  bystander effects, 
genomic instability, and adaptive responses that all 
three have been specifically observed in response to 
low dose radiation and a long time after the initial 
radiation exposure [3-8].  
The application of the new techniques and 
knowledge to radiobiology has started to provide 
some new insights into the mechanisms of low dose 
radiation action. This document will provide a brief 
summary of conventional mechanisms of radiation 
action on  targeted  effects, the major developments 
of non-targeted effects occurring after exposure to 
low doses of radiation and interaction between                    
the phenomena. 
 
 
EXPERIMENTAL METHODS 
 
Interaction of radiation with biological 
material 
 
The biological effects of ionizing radiation 
are primarily due to its ability to ionize the material 
in the cells, which make up the body’s tissues.                
By this mechanism energy is transferred from the 
radiation to the material. Radiation dose is the 
amount of energy per unit of biological material. 
Linear Energy Transfer (LET) is a physical 
parameter to describe average energy released per 
unit length of the track in traversed material. 
Radiations such as neutrons and alpha particles that 
cause dense ionization along their track are called 
high LET radiation. Low LET radiations such as              
X-ray and gamma radiation produce ionizations 
sparsely along their track and almost 
homogeneously within a cell. At the same dose, the 
low LET radiations induce the same number of 
radicals more sparsely within a cell, whereas the 
high LET radiations transfer most of their energy to 
a small region of the cell, therefore, high LET 
radiations are more destructive to biological 
material than low LET radiations. The localized 
DNA damage caused by dense ionizations from 
high LET radiations is more difficult to repair than 
the diffuse DNA damage caused by the sparse 
ionizations from low LET radiations [1,9]. 
Radiation induced ionizations may act 
directly on the cellular component molecules or 
through the indirect action of free radicals which are 
formed through radiation energy deposition in water 
molecules in cells or tissues. Radicals react with 
nearby molecules in a very short time resulting in 
breakage of chemical bonds or oxidation of the 
affected molecules. The traditional thinking has 
been that the biological effects of ionizing radiation 
occur in irradiated cells as a consequence of the 
DNA damage. This implies that biological effects 
occur only in irradiated cells, radiation traversal 
through the nucleus of the cell is a prerequisite to 
produce a biological response, and DNA is the 
target molecule in the cell. Three possible actions 
will occur when ionizing radiation sufficient to 
cause cellular damage i.e. (1) if the damage is too 
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severe, the cell may die; (2) if  the cell is not 
severely damaged, it might be able to repair itself 
and continue functioning, but could lose its ability 
to divide; or (3) a damaged normal cell                     
might mutate, which may cause cancer or genetic 
effects [9,10]. 
Low doses of radiation would tend to damage 
at the level of the cell or alter the genetic code 
(DNA) of irradiated cells, and thus the changes may 
not be observed for many years after exposure.              
The genes mainly involved in this cellular response 
to radiation are those involved in cell-cycle 
regulation, signal transduction, intercellular 
signaling, development and DNA damage repair. 
The mutation of genes result in alteration of their 
expression, loss of gene products (proteins) or 
change in protein properties or amounts that may 
disrupted the biochemical balance of the cell [1,11].   
 
 
RESULTS AND DISCUSSION 
 
Health effects of low dose radiation 
The primary health effects of low dose 
radiation are hereditary effects and the development 
of cancer. These diseases can affect a range of 
different organs/tissues in the body and arise 
naturally that  be relatively common in the general 
population. The information obtained from direct 
observation of excess disease in an irradiated 
population through epidemiological studies and  
indirect observation in animals and cultured cells as 
the experimental models of disease. 
Hereditary effects are those effects observed 
in the off spring of parent(s) that  has or have been 
irradiated prior to conception as the result of a 
mutation produced in the reproductive cells. 
Depending on whether the altered genes are 
dominant or recessive, these effects may appear in 
the exposed person's direct offspring, or may appear 
several generations later. Studies with experimental 
animals clearly demonstrate that radiation can cause 
hereditary effects whereas no evidence for the 
induction of hereditary effects by radiation in 
humans has been obtained [1-3]. 
Cancer is a general term used to describe 
major disturbances in the growth pattern of 
primitive, so called stem cells in body organs. These 
primitive stem cells normally develop and divide in 
a coordinated way to form the specialist cells                
of the organ but abnormal growth and arrested 
development can lead to a mass of cells in a given 
organ which is termed a solid tumor. There is strong 
epidemiological evidence that radiation exposure of 
humans can lead to excess solid tumors in many 
body organs and leukemia in the blood system. 
There is also growing information on the 
cellular/molecular mechanisms through which these 
cancers can arise. Human cancer arise from the 
accumulation of multiple genetic abnormalities 
which must occur in critical genes that regulate 
proliferation and differentiation. Cancer induced by 
radiation has long latent periods such as 10 years for 
leukemia and over 30 years for solid cancer [1-3]. 
Research and biological knowledge of 
molecular and cellular mechanisms confirm that 
carcinogenesis is a highly complex multi-step 
process. Generally carcinogenesis starts by mutation 
of one or more genes of the DNA of a single 
somatic cell in a body organ. This implies that 
mutations induced by radiation due to gene mutation 
and/or chromosomal damage that can be detected 
within 24 hours of radiation exposure are not 
directly responsible for initiating carcinogenesis                   
in normal human cells. Subsequent cancer 
development and the onset of malignancy are 
assured to proceed in a multistep model which each 
step has been associated with mutation or other 
changes involving cellular genes. However, such 
mutations induce genetic instability that make cells 
more sensitive to accumulation of additional genetic 
abnormalities caused by exposure to additional 
radiation doses, chemical mutagens and 
carcinogens, tumor promoters, oncogenic viruses, or 
their combinations. Cells may continue to carry 
genetic abnormalities for a long time until the 
expression of genes regulating differentiation is 
altered. No universal pattern of response has been 
identified and not all genes change in expression 
level following radiation exposure [2,3,10,11]. 
Radiation is well known to play role mainly 
in inducing initiating mutations in proto-oncogenes 
or tumour suppressor genes that have normal 
cellular functions in cell growth, development and 
regulation. Cancer initiation involves a loss of 
regulation of growth, reproduction and development 
in somatic stem cells, i.e the loss of control over            
the cell reproduction cycle and differentiation 
processes. Point mutations and chromosomal 
damage play roles in the initiation of neoplasia. 
Initiation can result from the inactivation of tumour 
suppressor genes, some of which play a central role 
in the control of the cell cycle. Although cells may 
have undergone initiating changes, they will not 
express their properties until they are stimulated or 
promoted to reproduce. The promoting agents may 
be independent of the initiation agent [2,12].                
The growth of cancer cells may also be regulated to 
some extent by the tissue microenvironment 
affected by radiation involving can reactive oxygen, 
inflammation and transforming growth factor                   
β (TGFβ) signaling [13]. The main drivers of low 
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dose radiation health effects are the direct induction 
of targeted mutations in DNA, the contribution of 
non-targeted and delayed effects distant from 
radiation-induced DNA lesions. 
The induction and development of cancer 
after radiation is not simply a matter of the stepwise 
accumulation of mutations in the DNA of the 
relevant cells. Moreover, the adaptation of cells and 
tissues to low dose radiation might cause them to 
become more resistant to cancer development.               
The radiation effects of radiation on the immune 
systems that recognize or destroy abnormal                   
cells could influence the possibility of cancer 
development.  
 
 
Targeted effects of low dose ionizing 
radiation 
 
When ionizing radiation traverses biological 
material, some energy depositions occur directly               
in biologically important molecules causing 
ionizations. The radiation  damage to biological 
systems were explained based on target theory of 
radiation which suggests that death of a cell after 
radiation exposure is caused by the inactivation of 
specific targets within cells. Cells contain at least 
one target as the critical site that must be hit by 
radiation so as to kill or change a cell. Therefore, 
radiation damage outside of the target should not 
cause cell death. It is widely accepted that nuclear 
DNA is the critical target for detrimental biological 
effects of radiation. The theory of DNA critical 
target not only could explain mechanisms in 
radiation biology but also accelerate the progress of 
cellular and molecular radiation biology [9].  
 
 
DNA as the target of radiation 
 
It has long been a central radiobiological 
dogma that the biological effects of ionizing 
radiation are the results of the direct ionization              
of cell structures, particularly DNA, or indirect 
ionization via free radicals as the water radiolysis 
products. The main subcellular target for radiation-
associated cellular alteration are the DNA molecules 
in the nucleus. Damage to DNA molecules residing 
in the chromosomes is the main initiating event of 
radiation that causes long-term harm to organs and 
tissues of the body. The  DNA codes for about 
30,000 genes that coordinate all functions in each 
cell that can be affected at low doses of radiation. 
Radiation is able to simultaneously damage both 
strands of DNA resulting in complex chemical 
changes. Reaction between free radicals as the 
results of water radiolysis, especially hydroxyl 
radical with DNA will produces damages on both 
the sugar and the bases of DNA that leads into 
single DNA lesions such as base damage (BD),  
abasic sites (AS), single strand breaks (SSBs), 
DNA-protein cross links (DPC), or double strand 
breaks (DSBs) as well as clustered DNA lesions 
(locally multiply damaged sites, LMDS). The latter 
might involve one or more DSB, several SSB as 
well as BD. Therefore, LMDS may be more 
difficult to repair or fail to repair [2,10].  
Cells have complex signal transduction, cell 
cycle checkpoint and repair pathways to respond to 
the DNA damage and to restore the genetic integrity 
of a cell. BD, AS and SSBs are repaired by different 
processes like base excision repair, nucleotide 
excision repair (NER), and single strand break 
repair. DPC are repaired by NER and homologous 
recombination repair (HRR).  DSBs are  the critical 
lesions that can lead to cell death via the formation 
of lethal chromosomal aberrations or the induction 
of apoptosis if not repaired appropriately. To protect 
cells from the potentially deleterious effects, there 
are two principal DSBs repair mechanisms i.e. HRR 
and non homologous end joining (NHEJ) which act 
at different phase of the cell cycle. Briefly, DSB 
repair by HR requires an undamaged template 
molecule that contains a homologous DNA 
sequence, typically on the sister chromatid in the S 
and G2 phases of the cell cycle. In contrast, NHEJ  
which may occur in all cell-cycle phases, does not 
require an undamaged partner and does not rely on 
extensive homologies between the recombining 
ends  [14-16].  
DSBs and LMDS are likely to be of greatest 
importance in terms of causing lasting mutations. 
Even the lowest doses of radiation may induce DNA 
damage that may be converted into DNA sequence 
mutations since none of the DNA repair systems is 
completely error free. Chromosome aberrations that 
arise from unrepaired or inaccurately repaired DSB 
represent a readily visible type of DNA damage 
caused by ionizing radiation that are observable 
during mitosis using microscope. Chromosome 
aberrations commonly induced by radiation are 
dicentrics, rings, acentric fragments, deletions, 
translocations, and anaphase bridges. The frequency 
of aberrations is radiation dose dependent and can 
be used as an indication of dose received under 
some conditions. The range of DNA damages                
lead to cellular endpoints such as chromosome 
aberrations, mutagenesis, and genomic instability 
which are contributing to malignant cell 
transformation. Damage to other cellular 
components (epigenetic changes) may influence the 
functioning of the cell and progression to the 
malignant state [1-3]. 
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Importantly, the key mutational events in 
cancer development are frequently dependent on the 
organ in which the irradiated cell is located and fall 
into two general categories, small specific mutations 
in single genes and mutations involving loss of 
DNA. Cells have a number of biochemical 
pathways capable of recognizing and dealing with 
specific forms of damage. One gene that plays a key 
role is the tumour suppressor TP53, which is lost or 
mutated in more than half of all human tumours. 
The p53 protein produced by the gene controls both 
arrest of the cell cycle and one pathway of apoptosis 
(the programmed cell death that is instrumental in 
preventing some damaged cells from progressing to 
the transformed, malignant growth stage). Some 
such biochemical pathways are also implicated in 
stress response or adaptation processes that act to 
limit the extent or outcome of damage [1,2].  
A series of several mutations (perhaps two to 
seven) in the cell genetic code are usually required 
to result in a fully transformed cell capable of 
leading to a cancer.  In spontaneous cancers, these 
mutations will have occurred randomly during life. 
Thus, even after initial cell transformation and 
promotion, further mutations are needed to complete 
the clonal transition from preneoplasia to               
cancer. The whole process is called multi-stage 
carcinogenesis [2,3,10]. Based on the classical 
radiation carcinogenesis, ionizing radiation damages 
primarily nuclear DNA inducing targeted DNA 
mutations in the unrepaired stem cells correctly  
thus initiating the cancer development process. 
Secondary mutations accumulate leading to 
development of a malignant neoplasm.  
 
 
Non-targeted effects of ionizing radiation 
 
The classic descriptions of radiation-induced 
damage in cells, as just discussed, are based on 
responses triggered by DNA damage in the cells 
exposed to radiation. In the past 15 years, there has 
been increasing acceptance that so-called non-
targeted effects can also occur in which biological 
responses that are not directly related to the amount 
of energy deposited in the DNA of the cells 
traversed by the radiation, but can result from non–
DNA-damage-initiated events and can be seen in 
non-irradiated cells. An essential feature of  non-
targeted effects is the effect that do not require a 
direct nuclear exposure to radiation to be expressed 
and are particularly significant at low doses 
radiation. The effects  considered to be non-targeted 
effects of radiation are genomic instability, 
bystander effects, and adaptive responses.                     
These three effects involve intracellular signaling       
or communication that may have in                        
common involvement of oxidative stress, 
inﬂammatory-like response pathways, and induction 
of cytokines/growth factors. The interactions and 
signaling induced are quite complex, for example, 
radiation can activate cell-mediated inﬂammatory 
processes that cause DNA damage in stem cells 
[17,18] or radiation-induced signals from ﬁbroblasts 
can induce apoptosis in transformed epithelial cells 
[19]. Although these effects have generally been 
considered in terms of relevance to carcinogenesis, 
late chronic side effects in irradiated normal tissues 
may be associated with similar oxidative and 
inﬂammatory effects [18,20] suggesting these 
phenomena could may play roles in the mechanisms 
of normal tissue damage. 
Genomic instability is the increase in 
chromosomal instability, mutations, apoptosis, or 
other deleterious effects in the progeny of irradiated 
cells, often many generations after the exposure  
[17,21,22]. The high frequency of genomic 
instability in progeny of irradiated cells of normal 
tissue origin is not consistent with a mutational 
mechanism. Bystander effects are cellular responses 
occurring in non irradiated cells that are near                 
to or sharing medium with irradiated cells [21,23]. 
The responses include increased reactive oxygen 
species (ROS), DNA damage, mutagenesis, changes 
in gene expression and  decreased clonogenic 
survival in bystander cells that can be seen after 
irradiation of a single cell in a population of 
hundreds of cells [21,23]. On the other hand, 
adaptive response is a phenomenon whereby the 
detrimental effects of DNA-damaging agents can be 
mitigated if the cells are exposed to a prior stress 
and low-dose ionizing radiation was first identified 
to have an effect [24]. This radioadaptive response 
is the acquirement of cellular resistance to the 
genotoxic effects of radiation by prior exposure to 
low-dose radiation. The potential relevance of these 
non-targeted effects to normal tissue radiation 
biology will be described briefly below.  
 
 
Radiation-induced genomic instability  
 
Induction of genomic instability can be  
described as if a single cell is irradiated and 
survives, it may produce daughter cells that over 
several generation have increasing numbers of 
alterations in their genomes, even though the 
daughter cells themselves were not irradiated.            
This phenomenon that surprisingly frequent event in 
the progeny of surviving cells  can be defined as the 
persistent production of genomic changes in the 
progeny of surviving cells after irradiation, which 
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could be detected as increased mutation rates                
on genes and DNA sequences and delayed 
chromosomal aberrations and reproductive cell 
death. The  survivors of irradiated cells showed 
different genetic lesions than initially occurred in 
the radiation exposed parental cells indicating that 
the target for induced instability is large [2]. 
There appear to be multiple pathways for 
initiating and perpetuating radiation-induced 
genomic instability and the relative contributions of 
different pathways may depend on the genetic 
background of the target cell or organism. A long 
term study of low dose rate (20-200 mGy/day)                
γ-ray-exposed C3H mice identified a contribution of 
indirect effects of radiation in the induction of 
complex chromosomal aberrations in spleen cells 
[25]. In utero irradiation of BALB/c mice has been 
observed to lead to a persistent elevation in 
mutation frequency at expanded simple tandem 
repeat (ESTR) loci in somatic tissues which can 
pass transgenerationally to an F1 generation [26]. 
Elevated mutation rates at an ESTR locus and at a 
protein-coding gene (hprt), possibly due to the 
presence of persistent DNA damage, were also 
observed in the first generation offspring of 
irradiated male mice [27]. The three studies above 
provide evidence for the induction of transmissible 
genomic instability by radiation in mice.  
The nature of directly induced damage and a 
reduced ability to repair DNA damage may promote 
instability. The process of genomic instability not 
only induced in progeny of directly irradiated cells 
but may also be induced in bystander cells. A study 
provides evidence for non direct induction of 
transmissible genomic instability. The authors 
ascribe this induction to factors released from 
macrophages including tumour necrosis factor-α, 
nitric oxide and superoxide [18]. It seems likely that 
there are multiple transmissible instabilities                    
that require improved functional definition                     
and mechanistic understanding before their 
importance in radiation-induced health effects can 
be properly assessed.  
 
 
Radiation-induced bystander effect 
 
Radiation-induced bystander effect is defined 
as the induction of biological effects in cells that are 
not directly traversed by radiation or a charged 
particle, but are neighbors of cells that were 
irradiated. These cells might have been in the same 
radiation environment or they might be non-
irradiated cells that received culture medium from 
irradiated cells. The phenomenon is in terms of 
chromosomal aberrations, alterations in gene 
expression and induction of cell lethality. The 
bystander  response can be considered as the 
strongest evidence in support of non-targeted 
radiation effects that were observed in in vivo and      
in in vitro [2].  
Studies using a charged particle microbeam 
provided the first clear-cut indication of a radiation-
induced bystander phenomenon. Following a low 
dose of alpha particles, a larger proportion of cells 
showed biological damage than was estimated to 
have been hit by an α-particle. To demonstrate the 
induction of a bystander effect unequivocally, 
studies were conducted in which a defined 
proportion of cells in a confluent monolayer that 
were irradiated individually with a defined number 
of α-particles. Changes in gene expression, mutation 
induction, delayed lethality, apoptosis and 
micronuclei formation were also described in cells 
exposed to very low fluences of a particles [28].  
Although the molecular mechanisms 
underlying the bystander effect are not yet clear, it 
is evident that intercellular signal transduction 
between irradiated cells (target cells) and 
unirradiated cells (bystander cells) could play a 
major role in multiple mechanisms of bystander 
responses or communication. Four possible models 
for intercellular signaling pathways, capable of 
producing the radiation-induced bystander response 
that have been proposed are through (a) medium or 
transmitted via gap junctions intercellular 
communication; (b) interactions between ligands 
and their specific receptors; (c) interaction between 
the secreted factors and their specific receptors; (d) 
plasma membranes [5,29,30]. Models (c) and (d) 
assume that irradiated and unirradiated cells are 
non-adjacent and distant from each other, and that 
the bystander transmission factors must be soluble 
elements secreted from the irradiated cells. 
Evidence from several systems implicates that there 
are a range of potential mediators of bystander 
signals secreted by cells after exposed radiation that 
can stimulate or modify responses in undamaged 
cells and even kill the cells that were not damaged 
that have been identified including ROS [29], 
reactive nitrogen species, nitric oxide [31], the 
cytokine such as interleukin-8 (IL-8) [32] and TGFβ 
[33], oxidative enzymes such as Cox-2 [21], the 
transcription factor NF-kB [22] and mitochondria 
[34]  and other inflammatory response markers [35]. 
Several studies with 3D tissue models have also 
demonstrated bystander responses and these 
responses can occur over signiﬁcant distances           
(e.g., up to 1 mm) and for times up to 48            
hours [30,36,37]. 
Recently, radiation-induced bystander 
responses were also observed in vivo [23,38,39] and 
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this can be associated with increased cancer risk. 
But it is important to note that in addition to 
ionising radiation, a number of other agents have 
been reported to induce bystander-type responses 
suggesting that ionizing radiation-induced bystander 
effects reflect a general stress response. This may 
have implications for the significance of bystander 
effects for low dose radiation risk assessment. The 
occurrence of radiation-induced bystander responses 
in vivo would be of relevance to  human health.  
Not all bystander effects are detrimental to 
the bystander cell. Bystander effect is a protective 
mechanism by the function of eliminating 
potentially damaged cells in the vicinity of radiation 
induced DNA damage by apoptosis and increased 
differentiation. Implications of bystander effects for 
radiation protection could be important and might 
contribute to better estimation of cancer risk.                     
In particular, bystander effect is potentially 
significant for radiation protection issues and may 
have implications for the applicability of the LNT 
model in extrapolating radiation risk data into the 
low dose region. 
 
 
Radiation-induced adaptive response 
 
Originally the radiation-induced adaptive 
response was described as the decrease in frequency 
of chromosome aberrations in irradiated human 
lymphocytes when the cells were treated with a low 
priming  dose  prior  to a larger challenge dose [40]. 
Since then, the observations have been reported in 
labs with a variety of test systems that has been seen 
in vitro and in vivo [22,41]. Adaptive response to 
radiation in cells is characterized by a reduction in 
radiobiological response in cells pretreated with an 
initial low dose (priming dose) of ionizing radiation 
activating a repair mechanism that reduces the 
response to a subsequent challenge larger dose. 
Apparently, the range of initial or priming doses is 
limited and the time for deliberating the challenge 
dose with a reasonable magnitude is critical [2]. 
The radioadaptive response is defined by a 
“window” for a priming dose (about 0.01 – 0.2 Gy) 
in culture cells which is the dose required to induce 
an effective protective signaling mechanism and an 
“interval period” between a priming and challenge 
exposure to radiation [3]. The radioadaptive 
response has an optimum dose range below 0.1 Gy 
[43], occurs in metabolically active cells but not in 
dormant G0 cells [16], represents an immediate 
early response being expressed maximally at 4–6 h 
after irradiation and continues for more than              
20 hours [17,42]. Higher doses are not only 
incapable of inducing adaptation, but also 
immediately erase the adapted condition [42], 
indicating an involvement of some feedback 
regulatory mechanisms. If the priming dose is over 
0.2 Gy, adaptive responses are barely induced, and 
when it is over 0.5 Gy, adaptive responses are 
almost never induced [43]. 
There have been numerous reports 
demonstrating the presence of adaptive response in 
a variety of mammalian cells observed using low 
LET radiations and various endpoints such as 
chromosomal aberrations [3], micronuclei formation 
[44], mutation induction and spectrum [45], and 
radiosensitivity [23] neoplastic transformation [46], 
apoptosis [5], cell proliferation [47], and cell              
killing [5].  
A possible molecular mechanism of adaptive 
response to low-dose ionizing irradiation has been 
related to the repair of DSBs and p53 protein played 
a key role in the adaptive response. The adaptive 
response to low-dose ionizing irradiation thus, 
favors the involvement of the NHEJ pathways. The 
p53 protein channels the radiation-induced DNA 
DSBs into an adaptive legitimate repair pathway, 
and hence turn off the signals to an alternative 
pathway to illegitimate repair and apoptosis [48]. 
Cytogenetic adaptive response of human 
lymphoblastoid cells  is used to determine the 
modification of gene expression in adapted cells and 
to identify the genes that are associated with 
reduction of radiation effects by a comprehensive 
assay using cDNA microarray analyses. Whereas 
genes associated with cellular proliferation, signal 
transduction, apoptosis, ubiquitin-dependent protein 
degradation, translation, protein modification and 
DNA double-strand break repair were down-
regulated, genes associated with base excision 
repair, cell cycle control, signal transduction, and 
stress response were up-regulated [49]. 
The impact on health of relatively short-lived 
modification in radiosensitivity is not clear. 
Radioadaptive response can be seen as a biological 
defense mechanism in which low-dose ionizing 
irradiation elicits cellular resistance to the genotoxic 
effects of subsequent irradiation. Since  adaptive 
response is demonstrated at low doses and dose-
rates, it may someday have an impact on radiation 
protection standards and regulations and may be 
useful in radiation therapy to protect normal tissue. 
 
 
Interrelationships among low dose 
responses to radiation 
 
It is unlikely to make a clear distinction 
between the phenomena since evidence for                     
an interrelation between radiation-induced 
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transmissible genomic instability, bystander effects 
and adaptive responses has become available that be 
reviewed below. 
Radiation-induced genomic instability and 
bystander effects are closely related regarding 
mechanisms and effect that persists for many 
generations.  These harmful effects are the same as 
those occurring in irradiated cells and are 
presumably a consequence of the deposition of 
energy in the cell nucleus. These untargeted effects 
are demonstrated in the descendants cells that have 
received damaging signals from the irradiated cells 
(radiation-induced genomic instability) or in cells 
that are in contact with irradiated cells or receive 
certain signals from irradiated cells (radiation-
induced bystander effects). Radiation-induced 
genomic instability is characterized by a number of 
delayed adverse responses such as chromosomal 
abnormalities, gene mutations and cell death. 
Similar effects, as well as responses that may be 
regarded as protective, have been attributed to 
bystander mechanisms. The process of genomic 
instability not only induced in progeny of                 
directly irradiated cells but may also be induced in 
bystander cells.  
The initial cross section for radiation damage 
is increased by the bystander effect, and cells that 
are affected by the bystander mechanism may 
remain at an increased risk of genetic change for 
many generations. There is accumulating evidence 
that radiation-induced genomic instability may be a 
consequence of bystander interactions involving 
intercellular signaling, production of cytokines and 
free radical generation.  Observations of roles for 
ROS and/or various cytokines in both responses 
have led to suggestions that the two responses may 
be interrelated [21,28].  
Normal cells have a control mechanism that 
normally suppresses genomic instability. Cells may 
normally suppress instability but that radiation may 
stimulate factors that overcome this suppression and 
promote an endogenous process. Exposure to 
ionizing radiation can result in the manifestation of 
a number of deleterious effects in the multiple 
generations of irradiated cells that increase the rate 
of acquisition of alterations in the genome. These 
dying cells constitute a risk to the cells in culture by 
releasing a variety of factors such as inflammatory 
cytokines, nitric oxide-dependent factors, potential 
nucleases and signaling molecules in addition to           
the peroxy radicals that can trigger potentially 
detrimental cellular responses. These reactive 
intermediates then contribute to a chronic pro-
oxidant environment that cycles over multiple 
generations, promoting chromosomal recombination 
and other phenotypes associated with genomic 
instability. The consequences of genomic instability 
includes such deleterious endpoints as chromosomal 
rearrangements, delayed mutation, DNA nucleotide 
repeat instability, cellular transformation and cell 
death [21]. It is likely that the process may be a 
major factor in determining the long term response 
of populations to low dose of ionizing radiation.  
The phenomena of radiation-induced genomic 
instability and bystander effects may reflect 
interrelated aspects of inflammatory-type responses 
to radiation-induced stress and injury and contribute 
to the variety of pathological consequences of 
radiation exposures. 
The term radioadaptive response indicated 
that the deleterious effects of low dose radiation 
may be attenuated by a priming low radiation dose 
that may serve to reduce the effect of subsequent 
higher dose exposures.  Contrary, the harmful 
effects of low dose radiation may be amplified due 
to induced bystander responses [21,36] which were 
not directly traversed by radiation, and which have 
resulted from some types of communication or 
signaling between the targeted cells and nearby  
non-targeted or bystander cells. Bystander effects 
and adaptive responses are two phenomena that 
modulate cellular responses to low doses of ionizing 
radiation that appear to be two conflicting low dose 
phenomena. Bystander effects on the other hand 
exaggerate the effects of low doses of radiation by 
eliciting detrimental effects in non-targeted cells, 
thus making the target for radiation effects greater 
than the volume irradiated. Adaptive responses 
generally indicate that low doses of radiation can 
reduce damage induced by a second challenging 
dose. Consequently bystander effects and adaptive 
responses have the potential to impact on the shape 
of the dose response profile at low doses of 
radiation [21,36,50].  
Increasing evidence that reactive oxygen and 
nitrogen species may play roles in correlation 
between adaptive response and bystander                 
effects [5,6,51]. Zhou et al. [45] have investigated 
the interaction between a specific bystander effects 
and adaptive responses. Interestingly, a low 
adapting dose of radiation decreased mutagenesis 
mediated by bystander in human hamster AL cells. 
Thus, the adaptive responses decreases non-targeted 
bystander mutagenesis. However bystander cells 
show an increase in sensitivity after a subsequent 
challenge with X-rays. The similarity and difference 
in various parameters that can modulate                
radiation-induced adaptive response and the 
bystander effect is that both are primarily low-dose 
phenomena. In general, there are more similarities 
than differences between the two phenomena.             
Both the adaptive response and the bystander effect 
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have been demonstrated by a range of biological 
endpoints including cell killing, oncogenic 
transformation, mutagenesis, chromosomal 
aberrations, induction of p53 protein, and DNA 
repair foci. Although bystander effects are                
not p53 dependent, there are reports that adaptive 
response, in some studies, is related to p53 function. 
It should be noted that cancer cells with mutated 
p53 protein can also demonstrate an adaptive 
response. Both phenomena involve signals                    
that mediate through either gap junctions or soluble 
mediators. 
Although adaptive response is largely 
protective in nature and the bystander response, in 
general, signifies detrimental effects, the two 
processes share many common characteristics. 
Although many of the bystander responses reported 
have been detrimental in nature, there are reported 
protective effects as well, for example, induction of 
apoptosis of potentially damaged cells. There are 
several signaling events that are common to               
both these low-dose phenomena and suggest that  
the adaptive response and the bystander effect share 
a common stress-related signaling lineage. If a cell 
need not actually be "hit" by radiation to show 
negative effects, this could affect radiation risk and 
protection standards. A better understanding of the 
mechanisms involved in the two processes and              
how they interact at the cellular, tissue, and                
organ levels will be important in obtaining a better 
and more accurate low-dose radiation risk 
assessment. 
 
 
CONCLUSION 
 
The untargeted and delayed effects associated 
with low dose radiation exposure that still poorly 
understood are genomic instability, bystander 
effects and adaptive response. Genomic instability 
and adaptive response cause a substantial reduction 
of the risk at low doses, while induction of 
detrimental bystander effects slightly increase                 
the risk. These non-targeted mechanisms have 
significant implications for understanding 
mechanisms of radiation action but the current state 
of knowledge does not suggest statements about 
whether these phenomena have implications for 
assessing radiation risk. 
Further studies are now needed to consider 
how the risk from low levels of radiation exposure 
might be influenced by these three phenomena. 
Therefore while some progress has been made in 
understanding these phenomena, it would be too 
early to consider revising current risk calculations 
on the basis of current studies. Scientific 
understanding of the processes contributing to 
radiation-induced disease will be used in refinement 
of  judgements on low dose risk. 
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